Risk of incident bleeding after acute kidney injury: A retrospective cohort study

J Crit Care. 2020 Oct:59:23-31. doi: 10.1016/j.jcrc.2020.05.003. Epub 2020 May 20.

Abstract

Purpose: End-stage kidney disease (ESKD) causes bleeding diathesis; however, whether these findings are extrapolable to acute kidney injury (AKI) remains uncertain. We assessed whether AKI is associated with an increased risk of bleeding.

Methods: Single-center retrospective cohort study, excluding readmissions, admissions <24 h, ESKD or kidney transplants. The primary outcome was the development of incident bleeding analyzed by multivariate time-dependent Cox models.

Results: In 1001 patients, bleeding occurred in 48% of AKI and 57% of non-AKI patients (p = .007). To identify predictors of incident bleeding, we excluded patients who bled before ICU (n = 488). In bleeding-free patients (n = 513), we observed a trend toward higher risks of bleeding in AKI (22% vs. 16%, p = .06), and a higher risk of bleeding in AKI-requiring dialysis (38% vs. 17%, p = .01). Cirrhosis, AKI-requiring dialysis, anticoagulation, and coronary artery disease were associated with bleeding (HR 3.67, 95%CI:1.33-10.25; HR 2.82, 95%CI:1.26-6.32; HR 2.34, 95%CI:1.45-3.80; and HR 1.84, 95%CI:1.06-3.20, respectively), while SOFA score and sepsis had a protective association (HR 0.92 95%CI:0.84-0.99 and HR 0.55, 95%CI:0.34-0.91, respectively). Incident bleeding was not associated with mortality.

Conclusions: AKI-requiring dialysis was associated with incident bleeding, independent of anticoagulant administration. Studies are needed to better understand how AKI affects coagulation and clinical outcomes.

Keywords: Acute kidney injury; Bleeding; Hemorrhage; Outcomes; Time-dependent cox model.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / therapy*
  • Aged
  • Anticoagulants / adverse effects
  • Coronary Artery Disease / complications
  • Critical Care / methods*
  • Critical Illness
  • Female
  • Follow-Up Studies
  • Hemorrhage / epidemiology*
  • Hemorrhage / etiology*
  • Hemorrhage / mortality
  • Humans
  • Incidence
  • Length of Stay
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Renal Dialysis / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Sepsis / complications
  • Treatment Outcome

Substances

  • Anticoagulants